Actively Recruiting
Study Comparing How Patients and Healthcare Providers Value Different Heart Disease Outcomes in Coronary Artery Disease
Led by Xijing Hospital · Updated on 2026-01-30
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how patients and medical staff value different components of composite endpoints often used in cardiovascular clinical trials, especially for coronary artery disease CAD. The study aims to better understand the relative importance of events like myocardial infarction, stroke, and others compared to death, as opinions may differ between patients and healthcare providers. This observational study will help clarify how weighting these endpoints could improve trial interpretations. Participants include patients with acute or chronic coronary syndrome who have undergone percutaneous coronary intervention, as well as healthcare providers treating CAD. Both groups will complete a questionnaire that assesses how they weigh various clinical events relative to death. The study focuses on collecting and comparing these preferences to understand any differences. Participants will complete the questionnaire before hospital discharge. The study measures the relative weights assigned to myocardial infarction, stroke, cardiopulmonary resuscitation, procedural complications, major bleeding, acute kidney injury, revascularization, and rehospitalization compared to death. This observational process involves no treatment but gathers data on preferences, with total involvement lasting from enrollment until questionnaire completion before discharge.
CONDITIONS
Brief Title
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
Research Team
R
Ruining Zhang, BSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here